INTRODUCTION :- Laparoscopic cholecystectomy is very commonly performed surgery for symptomatic
cholelithiasis. There is very low risk of infective complications in elective Laparoscopic cholecystectomy
and hence standard guideline doesn't recommend prophylactic antibiotic usage for low risk cases. However it is very
commonly practicised in dosage and duration inconsistent among various surgeons. This study is being done to assess the
efcacy of single dose antibiotic prophylaxis over multiple dose in the prevention of surgical site infection in patients
undergoing elective laparoscopic cholecystectomy to avoid antibiotic resistance and overuse of it .
METHODS: The study included 60 patients admitted for elective Laparoscopic cholecystectomy. First 30 patients received
injectable ceftriaxone 1 gram intravenous peri-operatively, rst dose twelve hour before surgery and second dose half hour
before surgical incision and then followed by injection (conventional dose) ceftriaxone 1 gram/day iv twice daily for the rst 5-7
days post-operatively. Next 30 was dened as the single dose (post-operative) antibiotic patients , this group were given only
single dosage of injectable ceftriaxone 1 gram intravenous post-operatively.operation-room anesthetic assistant administered
prophylactic antibiotics at induction of anaesthesia to all the patients. On the third, fth, tenth and fteenth days post
operatively, based on Southampton scoring system the wound was seen and grading of the infection was done
RESULT: The post-operative surgical site infection rate in group receiving single dose was 7.76 % and that in multiple dose
group was found to be 6.67% . Chi- square test was used to analyse the data and the difference in the rate of SSI in both the
groups was found to be statistically insignicant.
CONCLUSION: There is no signicant difference in the outcome of elective laparoscopic cholecystectomy in terms of post
operative surgical site infection in single dose and multiple dose group. Also single dose of antibiotics are more patient
compliant, cost effective, have less adverse effects and reduce the incidence of antibiotic resistance